The system was used for treatment.A batch record review of kit lot d128 was performed.There were no nonconformances associated with this lot.This lot met release requirements.The uvadex lot number was not provided, as it was not administered.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories, clot observed and alarm #17: return pressure.No trends were detected.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).Device not returned.
|
Customer reported alarm #17: return pressure, at 583ml whole blood processed.Blood prime treatment in double needle mode.Customer stated that they had poor flow rate from start of the treatment.Collect and return flow rate was at 10ml/min.Customer stated that she could not reset the alarm because the return pressure was too high.Css advised customer to disconnect the return line from patient access, open the blue clamp and check the return pressure.Css advised to administer a saline bolus to waste to flush and check the return line.Customer stated that clots came out of the return line.Css advised customer to abort the treatment.Customer agreed and aborted the treatment.Customer reported the patient was in stable condition.The product was not returned for investigation.
|